HIRTY-TWO years after the first description of normal-pressure hydrocephalus (NPH), 1,10 selection of the opening, closing, or, more appropriately, working pressure of shunts is a matter of continuing controversy. In most larger studies medium-pressure shunts were used. 3, 7, 8, 13 In others low-pressure 17, 22 or high-pressure 2, 15 valves were preferred. Many investigators inserted shunts of various working pressures without reporting the criteria for their choice or without comparing their efficacy. 9, 12, 16, 21, 25 Vanneste, et al., 30 did not find any differences between the various working pressures. McQuarrie and colleagues 18 observed better results with low-pressure than with medium-pressure shunts in a retrospective study of 72 patients who had NPH. In contrast, in the study conducted by Larsson and associates, 15 13 patients improved with programmable shunts that were set at a high pressure without further improvement at medium-and low-pressure settings.
Clinical Material and Methods

Measurement of Gait Disturbance and Dementia
Gait disturbance was quantified by using a gait scale, described in detail elsewhere, 5 to evaluate the presence of 10 features of gait and to measure the number of steps and seconds required for a 10-m walk. Dementia was assessed by using a dementia scale that is composed of the 10-word, digit span forward and backward, trail making, and finger tapping tests. To create a single neurological outcome measure, we added the scores for gait (range and dementia (range , and the totals comprised the NPH scale (range 6-80). The modified Rankin scale (mRS), used to obtain a disability grade, was extended to a 7-point scale by inserting mRS Grade 4 (defined as moderate disability, partially independent, and needing assistance for Ͻ 50% of the day).
Eligibility Criteria
Between September 1990 and July 1995 101 patients with NPH were enrolled in the study because they fulfilled the following inclusion criteria: 1) a gradually developed gait disturbance in both legs, unexplained by other conditions, and a gait scale score of at least 12; 2) a mild-tomoderate cognitive deficit without aphasia, emerging with or after the gait disturbance, and a dementia scale score of at least 12; 3) a disability mRS grade of at least 2; and 4) a computerized tomography (CT) scan showing communicating hydrocephalus with an Evans' index of 0.3 or greater and a ventricular index greater than 0.8, 5 without clinically relevant parenchymal lesions, the sum of the four largest sulci at the convexity being less than 25 mm (real size).
Exclusion criteria included any of the following: acute or subacute symptomatic NPH within 3 months of a causative incident, patient age 85 years or older, severe comorbidity with restricted life expectancy, or contraindications for surgery.
Study Design
All patients in the study underwent a lumbar constantflow infusion test, 14 and a Medos Hakim spring-ball valve shunt (Johnson & Johnson Medos S.A., Le Locle, Switzerland) was placed in each patient, irrespective of the Rcsf value. The working pressure of the valve was measured just before implantation in 28 of our patients. The patients were randomized to receive a low-pressure ventriculoperitoneal shunt (LPV; 40 Ϯ 10 mm H 2 O) or a medium high-pressure ventriculoperitoneal shunt (MPV; 100 Ϯ 10 mm H 2 O). Randomization was maintained by telephone communication between the local coordinator and the study center. Shunts were allocated to patients according to the randomization lists prepared for each of the four centers separately. The gait and dementia scale scores and the mRS grades were determined prior to and 1, 3, 6, 9, and 12 months after surgery. Computerized tomography scans were obtained preoperatively and at 1, 6, and 12 months postoperatively.
Clinical and CT findings that raised suspicion of shunt failure included any of the following: 1) no clinical improvement and no reduction in ventricular size 3 months after surgery; 2) clinical deterioration, defined as an increase of 15% in the NPH scale and a reduction of one grade in the mRS; or 3) increase in ventricular size. In these cases the infusion test was repeated. The shunt was revised if the Rcsf was found to exceed 12 mm Hg/ml/ minute or if the Rcsf value was equal to or higher than the preoperative Rcsf value. Shunt dysfunctions caused by displacement or disconnection also required surgical treatment. For patients with proven shunt failure, follow up extended 12 months after the last operation.
Outcome Measures
Primary outcome measures were determined by the differences between the preoperative and the last NPH scale scores and mRS grades. Because it proved easier to measure improvement by starting at a high rather than low level of the NPH scale, changes in the NPH scale score were expressed as a percentage of the preoperative value. For instance, for NPH scale scores of 60 at study entry and 45 at 12 months, improvement was calculated as: [(60 Ϫ 45)/60] ϫ 100 = 25%. The more even distribution of disabilities across mRS grades justified the use of numerical grade differences. Secondary outcome measures were determined by differences between preoperative NPH scale scores and mRS grades and the means of the follow-up scores and grades as well as changes in gait and dementia scale scores. Improvement was classified using primary outcome measures (Table 1) .
Follow-Up Evaluation
Of the 101 patients five died of diseases that were unrelated to the shunt before the first follow-up examination at 1 month. Causes of death included stroke, cardiac failure, mesenteric arterial thrombosis, pneumonia, and head injury. Therefore, shunt working pressure could be correlated with outcome for 96 patients. Eleven patients, five in the LPV shunt group and six in the MPV shunt group, died during the follow-up period as a result of pneumonia (three patients), cardiac failure (two patients), stroke (two patients), peritonitis (one patient), and unknown causes (three patients). One patient was lost to follow up after 3 months because he returned to his native country, leaving 84 patients for whom complete 12-month follow-up data were available. The mean follow-up periods were 10.9 Ϯ 3.1 months in the LPV shunt group and 10.7 Ϯ 3.2 months in the MPV shunt group.
Intention-to-Treat and Efficacy Analyses
The results of shunt placement were studied by com- paring the means of primary and secondary outcome measures for the 49 patients in the LPV shunt group and the 47 patients in the MPV shunt group by using Student's ttest. The proportions of patients who exhibited improvement were compared between both groups by using the chi-square test. Intention-to-treat analysis was performed using all available outcome information at 12 months or the last follow-up examination. The 11 patients who died and the patient who was lost to follow up were categorized as unimproved. For efficacy analysis, all known serious events that were unrelated to NPH and clearly interfered with neurological function were excluded. Thus for the 11 patients who died and another 17 patients who suffered clinically significant events, such as stroke or hip fracture, the results of the last follow-up examination performed before this event were used to calculate the outcome measure. Twelve of these events occurred in the MPV shunt group and five in LPV shunt group.
Complications and Ventricular Size
Any accumulation of subdural fluid, however small, that was seen on a follow-up CT scan was recorded as a subdural effusion (SDE). The number of patients in whom an SDE was revealed and the influence of SDE on outcome were compared in the LPV and MPV shunt groups. All other complications of shunt placement were carefully recorded. Reduction in ventricular size was expressed as the reduction rate, which was calculated by dividing the preoperative ventricular index by the ventricular index measured on the last follow-up CT scan.
Results
The 96 patients who could be evaluated-55 men and 41 women-were adequately randomized across the LPV and MPV shunt groups ( Table 2) . Eleven patients had chronic symptomatic NPH (seven in the LPV shunt group and four in the MPV shunt group); the remaining 85 cases were idiopathic.
Working Pressure of the Shunt
The working pressure of the shunt was measured in 28 patients, 14 of whom had an LPV and 14 of whom had an MPV shunt. The mean working pressure for patients in the LPV shunt group was 40.4 Ϯ 8.7 mm H 2 O with a range of 30 to 60 mm H 2 O; that for patients in the MPV shunt group was 100 Ϯ 15.6 mm H 2 O, range 80 to 130 mm H 2 O. Opening pressure did not correspond to the value specified by the manufacturer in eight cases; however, in seven of these cases this difference was only 5 to 10 mm H 2 O and in one case it was 20 mm H 2 O.
Outcome After Shunt Placement
Intention-to-treat analysis revealed clinically relevant differences in outcome after 1 year between patients in the LPV and MPV shunt groups (Table 3 ). The last dementia scale scores were significantly better for patients in the LPV shunt group and the last mRS grades came close to significance. Efficacy analysis yielded smaller differences between the two groups because of the exclusion of deaths and invalidating events unrelated to NPH, which occurred more frequently in the MPV shunt group.
Primary outcome measures were used to calculate the proportion of individuals in both groups who responded to shunt placement (Table 4) . Again, patients did better with LPV than with MPV shunts, the greater differences occurring in mRS grades according to intention-to-treat analysis (p = 0.06).
Complications of Shunt Placement
Subdural effusions were the most frequent complication. They were found in 53% of our patients (Table 5 ) and were bilateral in 80% of those cases. Subdural effusions were already visible on the first follow-up CT scan in 84% of patients and resolved spontaneously in 39% of cases. Of the 61% of SDEs that persisted until the last follow-up examination, the volume of the lesions decreased in 50%. The majority of SDEs were hypodense; some contained hyperdense portions and only a few were fully hyperdense. The difference between the two groups was strik- ing because SDEs were present in 71% of patients with LPV shunts and in 34% of patients with MPV shunts (p = 0.0002).
The influence of subdural effusions on outcome was limited for both the LPV and MPV shunt groups (Table 6 ). Clinically most SDEs seemed to be asymptomatic. Surgical evacuation was necessary in eight cases, four from each treatment group.
All cases of extraperitoneal or ventricular displacement, disconnection of the shunt, and infection required surgical treatment.
Ventricular Width
Measurement of cerebrospinal fluid (CSF) spaces on CT scans yielded a significantly greater reduction in ventricular size after shunt placement in patients with an LPV shunt than in those with an MPV shunt (p = 0.009) and also in patients with SDEs compared with those without SDEs (p Ͻ 0.001).
Discussion
The Dutch Normal-Pressure Hydrocephalus Study is the first trial in which LPV and MPV shunts have been compared according to a prospective and randomized design. Intention-to-treat analysis yielded a strong tendency toward better results for patients with an LPV shunt compared with those with an MPV shunt, achieving statistical significance only with the dementia scale and almost achieving it with the mRS. The only corroborating evidence for these results comes from the retrospective study conducted by McQuarrie and colleagues. 18 For NPH patients with early disease, the use of low-pressure shunts resulted significantly more often in improvement in gait and reduction in ventricular size.
Shunt Characteristics
The Medos Hakim shunt was selected because its actual working pressure corresponds best to the manufacturer's specifications and remains constant over time. 28 Trost, et al., 28 tested different types of shunts in vitro and concluded that the Medos Hakim spring-ball valve had an excellent pressure-flow relationship and a stable prolonged reliability. For other shunt types they found deviations of up to 800%. We measured the working pressure of the valve just before implantation. Deviations from the manufacturer's specifications were relatively small for both shunt types, and the range of working pressures did not overlap.
Subdural Effusions
Subdural effusions have been observed in up to 28% of patients with NPH who have shunts. 2, 3, 7, 9, 12, 16, 19, 21, 24, 29 If cases of transient effusions are excluded, 32% of our patients exhibited SDE. This high incidence can be attributed partly to the many follow-up CT scans and the very strict CT criteria. Other reasons are the low resistance of the Medos Hakim system, leading to greater CSF flow and, of course, the placement of LPV shunts in one-half of the patients. The LPV shunts were indeed accompanied by a significantly higher percentage of SDEs.
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Dutch Normal-Pressure Hydrocephalus Study Subdural effusions have to be characterized as a severe complication for the eight patients who required surgical evacuation. However, overall outcome did not seem to be affected by SDE because no differences could be detected between patients with and without SDE. An interesting finding of this study is that outcome was better for patients with an LPV shunt despite the many SDEs. The LPV shunt group also displayed a significantly larger reduction in ventricular volume because of the valve as well as the SDEs.
493
24 7 requiring surgical therapy 8 4 4 ventricular displacement 9 6 3 extraperitoneal localization 7 5 2 infection 3 0 3 disconnection 3 2 1 transient sixth cranial nerve paresis 3 2 1 epileptic seizures 1 0 1 intracerebral hematoma 2 1 1 total 79 51 28
How Does a Shunt Work?
The common opinion is that shunts remove excess CSF, resulting in a decrease in CSF pressure. Unfolding of the brain is then thought to take place only when ventricular pressure is lower than intraparenchymal venous pressure. 4 The larger the ventricles, the greater the pressure gradient required for reversal of hydrocephalus. 11 Pang and Altschuler 20 described 12 patients with very large ventricles and low CSF pressure whose symptoms and signs of shunt malfunction had to be treated by external ventricular drainage at subzero pressure. In a series of 60 patients with NPH, those with a baseline pressure below 140 mm H 2 O before shunt placement benefited little from mediumpressure shunts. 17 Magnaes 17 advocated a shunt working pressure of 50 mm H 2 O below CSF pressure. The mean baseline pressure in our study was 150 mm H 2 O, the lowest value being 70 mm H 2 O. On the basis of the aforementioned observations, therefore, an LPV shunt would be the better choice.
Some investigators hold the view that shunts are effective primarily because the Rcsf is lowered. In one study Rcsf and baseline CSF pressure were measured before and after shunt implantation. 26 The postoperative baseline pressure was not related to the working pressure of the shunt, but the reduction in baseline pressure correlated well with the reduction in Rcsf. Patients with NPH who received a programmable shunt system improved only during the first 3 months at a high working pressure. In this period baseline pressure remained unchanged, indicating that the improvement was due to a reduction in Rcsf. 15 If reduction of CSF outflow resistance is considered more important for ventricular reduction mediumpressure shunts with a low resistance might be preferred.
The better outcome and the greater decrease in ventricular size in patients with LPV shunts indicate that shunt function is certainly determined by working pressure and thus by the gradients among intraparenchymal venous pressure, ventricular pressure, and shunt working pressure. The contribution of Rcsf reduction is less clear. Studies in which the function of shunts with variable resistance and the same working pressure are compared are not available. The high incidence of SDEs following shunt placement with the low-resistance Medos Hakim valve perhaps demonstrates that shunt resistance is important. An argument against the reduction-of-Rcsf hypothesis is the fact that postoperative normalization of Rcsf in a few of our patients with an MPV shunt did not lead to improvement. Furthermore, prediction of outcome by Rcsf was somewhat disappointing, 6 suggesting that a disturbance of Rcsf is not the only pathogenic factor in NPH and that normalization of Rcsf is not the most important shunt function.
Treatment of Overdrainage
We advocate the use of LPV shunts for NPH, but how does one prevent overdrainage? One solution is the use of an antisiphon device that reduces CSF flow when the patient is in the upright position. However, this reduction of CSF flow carries the risk of underdrainage 23 and siphoning alone does not explain the large difference in the development of SDEs between LPV and MPV shunts. The working pressures of the two differ by only 60 mm H 2 O, which pales into insignificance besides the hydrostatic pressure of the long distal catheter.
Variable resistance or flow-regulated valves, like the Orbis-Sigma Valve (Cordis Corp., Miami, FL), might be an answer; however, subdural hematomas and slit ventricles also occur after insertion of this shunt. 27, 31 The advantages of a programmable valve such as the Medos Hakim with 18 pressure settings are that shunt pressure can be better adjusted to CSF dynamics and the valve can be reprogrammed after implantation to prevent or treat overdrainage. 4 
Conclusions
Outcome in our 96 patients who had NPH was better for those who received the LPV rather than the MPV nonprogrammable Medos Hakim shunt, although the differences did not reach statistical significance for most of the outcome measures. The incidence of SDEs was high, but their influence on outcome was limited. The high rate of complications of shunt placement is an additional indication of the need to proceed with caution in this vulnerable NPH population. Based on the results of this study, treatment of NPH with a low-pressure shunt is recommended.
